Search Result "ultra-high risk"


The Ultra High Risk Approach to Define Psychosis Risk

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 346-350
Author(s): Alison R. Yung, Paolo Fusar-Poli, Barnaby Nelson

Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 570-575
Author(s): Gregor E. Berger, Stephen J. Wood, Margaret Ross, Clare A. Hamer, R. Mark Wellard, Gaby Pell, Lisa Phillips, Barnaby Nelson, G. Paul Amminger, Alison R. Yung, Graeme Jackson, Dennis Velakoulis, Christos Pantelis, Husseini Manji, Patrick D McGorry

Reliability and Validity of the Comprehensive Assessment of the at Risk Mental State, Italian Version (CAARMS-I)

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 386-391
Author(s): P. Fusar-Poli, R. Hobson, M. Raduelli, U. Balottin

Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 566-569
Author(s): Marta Hauser, Georg Juckel

Glutamate and Psychosis Risk

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 466-478
Author(s): Alice Egerton, Paolo Fusar-Poli, James M. Stone

The Assessment of Attenuated Psychotic Symptoms in Adolescents: Concepts, Practical Approaches and Prediction of Risk

Journal: Adolescent Psychiatry
Volume: 2 Issue: 2 Year: 2012 Page: 153-162
Author(s): Rahel Pearson,Barbara Stuart,Rachel Loewy

Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 550-557
Author(s): Stephan Ruhrmann, Joachim Klosterkotter, Mitja Bodatsch, Andreas Bechdolf, Benno Graf Schimmelmann, Alexandra Nikolaides, Desiree Hilboll, Frauke Schultze-Lutter

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 32 Year: 2012 Page: 5036-5044
Author(s): Floor J. van der Meer,Eva Velthorst,Carin J. Meijer,Marise W.J. Machielsen,Lieuwe de Haan

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 12 Year: 2012 Page: 1568-1579
Author(s): Martin Bauer, Nicole Praschak-Rieder, Siegfried Kasper, Matthaus Willeit

Cognitive Behavioral Therapy for Adolescents at Clinical High Risk for Psychosis

Journal: Adolescent Psychiatry
Volume: 2 Issue: 2 Year: 2012 Page: 172-181
Author(s): Kate V. Hardy,Rachel Loewy

Previous   Next

Go To   Results 1 - 1 of 169

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy